News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Burzynski Research Institute Presents Promising Phase II Data on Malignant Glioma



11/21/2008 8:45:48 AM

HOUSTON & LAS VEGAS--(BUSINESS WIRE)--Today at the 13th Annual Scientific Meeting of the Society for Neuro-Oncology, BRI announced encouraging results from the ongoing Phase II clinical trials of two of its investigational drugs, Atengenal (A10) and Astugenal (AS2-1), defined as antineoplastons therapy (ANP). The meeting is currently taking place in Loews Lake, Las Vegas, Nevada.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES